Comparison of focused and unfocused ESWT in treatment of erectile dysfunction

References

• Kaya E, Sikka SC, Kadowitz PJ, et al. Aging and sexual health: getting to the problem. Aging Male. 2017;20:65–80.
   PubMed Web of Science ®Google Scholar
• Almehmadi Y, Yassin DJ, Yassin AA. Erectile dysfunction is a prognostic indicator of comorbidities in men with late onset hypogonadism. Aging Male. 2015;18:186–194.
   PubMed Web of Science ®Google Scholar
• Campbell JD, Trock BJ, Oppenheim AR, et al. Meta-analysis of randomized controlled trials that assess the efficacy of low-intensity shockwave therapy for the treatment of erectile dysfunction. Ther Adv Urol. 2019;11:1756287219838364.
   Web of Science ®Google Scholar
• Faix A, Chevallier D. Low-intensity extracorporeal shockwave therapy for erectile dysfunction: a new option? Rev Med Suisse. 2019;15(642):590–595.
   PubMedGoogle Scholar
• Zhu GQ, Jeon SH, Bae WJ, et al. Efficient promotion of autophagy and angiogenesis using mesenchymal stem cell therapy enhanced by the low-energy shock waves in the treatment of erectile dysfunction. Stem Cells Int. 2018;2018:1302672.
   PubMed Web of Science ®Google Scholar
• Gruenwald I, Appel B, Vardi Y. Low-intensity extracorporeal shock wave therapy—a novel effective treatment for erectile dysfunction in severe ED patients who respond poorly to PDE5 inhibitor therapy. J Sex Med. 2012;9:259–264.
   PubMed Web of Science ®Google Scholar
• Vardi Y, Appel B, Jacob G, et al. Can low-intensity extracorporeal shockwave therapy improve erectile function? A 6-month follow-up pilot study in patients with organic erectile dysfunction. Eur Urol. 2010;58:243–248.
   PubMed Web of Science ®Google Scholar
• Chung E, Cartmill R. Evaluation of clinical efficacy, safety and patient satisfaction rate after low-intensity extracorporeal shockwave therapy for the treatment of male erectile dysfunction: an Australian first open-label single-arm prospective clinical trial. BJU Int. 2015;115:46–49.
   PubMed Web of Science ®Google Scholar
• Wang B, Ning H, Reed-Maldonado AB, et al. Low-intensity extracorporeal shock wave therapy enhances brain-derived neurotrophic factor expression through PERK/ATF4 signaling pathway. Int J Mol Sci. 2017;18:433.
   Web of Science ®Google Scholar
• Zou ZJ, Tang LY, Liu ZH, et al. Short-term efficacy and safety of low-intensity extracorporeal shock wave therapy in erectile dysfunction: a systematic review and meta-analysis. Int Braz J Urol. 2017;43:805–821.
   PubMed Web of Science ®Google Scholar
• Fode M, Lowenstein L, Reisman Y. Low-intensity extracorporeal shockwave therapy in sexual medicine: a questionnaire-based assessment of knowledge, clinical practice patterns, and attitudes in sexual medicine practitioners. Sex Med. 2017;5(2):94–98.
   Web of Science ®Google Scholar
• Chung HS, Shin MH, Park K. Association between hand-grip strength and erectile dysfunction in older men. Aging Male. 2018;21:225–230.
   PubMed Web of Science ®Google Scholar
• Amano T, Earle C, Imao T, et al. Are urge incontinence and aging risk factors of erectile dysfunction in patients with male lower urinary tract symptoms? Aging Male. 2016;19:54–57.
   PubMed Web of Science ®Google Scholar
• Shigehara K, Konaka H, Ijima M, et al. The correlation between highly sensitive C-reactive protein levels and erectile function among men with late-onset hypogonadism. Aging Male. 2016;19:239–243.
   PubMed Web of Science ®Google Scholar
• Dursun M, Besiroglu H, Cakir SS, et al. Increased visceral adiposity index associated with sexual dysfunction in men. Aging Male. 2018;21:187–192.
   PubMed Web of Science ®Google Scholar
• Panach-Navarrete J, Martínez-Jabaloyas JM, DE-SDT Study Group. The influence of comorbidities on the aging males' symptoms scale in patients with erectile dysfunction. Aging Male. 2017;20:146–152.
   PubMed Web of Science ®Google Scholar
• Yu XH, Zhao J, Zhang SC, et al. The impact of age, BMI and sex hormone on aging males' symptoms and the international index of erectile function scores. Aging Male. 2017;20:235–240.
   PubMed Web of Science ®Google Scholar
• Patel P, Fode M, Lue T, et al. Should low-intensity extracorporeal shockwave therapy be the first-line erectile dysfunction treatment for nonresponders to phosphodiesterase type 5 inhibition? Eur Urol Focus. 2019. DOI:10.1016/j.euf.2019.02.004
   Google Scholar
• Clavijo RI, Kohn TP, Kohn JR, et al. Effects of low-intensity extracorporeal shockwave therapy on erectile dysfunction: a systematic review and meta-analysis. J Sex Med. 2017;14:27–35.
   PubMed Web of Science ®Google Scholar
• Lu Z, Lin G, Reed-Maldonado A, et al. Low-intensity extracorporeal shock wave treatment improves erectile function: a systematic review and meta-analysis. Eur Urol. 2017;71:223–233.
   PubMed Web of Science ®Google Scholar
• Qiu X, Lin G, Xin Z, et al. Effects of low-energy shockwave therapy on the erectile function and tissue of a diabetic rat model. J Sex Med. 2013;10:738–746.
   PubMed Web of Science ®Google Scholar
• Li H, Matheu MP, Sun F. Low-energy shock wave therapy ameliorates erectile dysfunction in a pelvic neurovascular injuries rat model. Transl Androl Urol. 2016;5:977–979.
   PubMed Web of Science ®Google Scholar
• Srini VS, Reddy RK, Shultz T. Low intensity extracorporeal shockwave therapy for erectile dysfunction: a study in an Indian population. Can J Urol. 2015;22:7614–7622.
   PubMed Web of Science ®Google Scholar
• Fojecki GL, Tiessen S, Osther P. Effect of low-energy linear shockwave therapy on erectile dysfunction-a double-blinded, sham-controlled, randomized clinical trial. J Sex Med. 2017;14:106–112.
   PubMed Web of Science ®Google Scholar
• Vardi Y, Appel B, Kilchevsky A, et al. Does low intensity extracorporeal shock wave therapy have a physiological effect on erectile function? Short-term results of a randomized, double-blind, sham controlled study. J Urol. 2012;187:1769–1775.
   PubMed Web of Science ®Google Scholar
• Motil I, Kubis I, Sramkova T. Treatment of vasculogenic erectile dysfunction with Piezowave device. Application of low intensity shockwaves using novel linear shockwave tissue coverage (LSTC-ED®) technique. A prospective, multicentric, placebo-controlled study. Asm. 2016;6:15–18.
   Google Scholar